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A case of alopecia areata followed by relapsing polychondritis is presented. Similar cases from the literature are reviewed and
speculation about the relationship of these diseases is oﬀered. Although the occurrence of these diseases together could be
coincidental, an association seems immunologically plausible. Thus, relapsing polychondritis might be an unusual systemic
manifestation of alopecia areata.
1.Introduction
Alopecia areata aﬀects 1% to 2% of the general population
[1]. It has been associated with a number of autoimmune
diseases, including thyroid disorders, vitiligo, and possibly
atopic dermatitis [2]. Case reports have suggested an asso-
ciation with myasthenia gravis, diabetes mellitus, Addison
disease, and even common variable immunodeﬁciency,
amongst others [3, 4]. Twice previously, alopecia areata and
relapsing polychondritis have been reported in the same
patient [5, 6] We wish to report a third case.
2.CaseReport
A 71-year-old retired welder with a 28-year history of
alopecia universalis developed poison ivy on the right
forearm. Three weeks later, after complete healing of the
poison ivy, the patient noted pain, redness, and tenderness
of his right ear. The earlobe was spared. Shortly thereafter,
the patient’s nose became red and tender, and his left
ear developed similar changes (Figure 1). He was treated
with antibiotics with no improvement. Because of severe,
persistent inﬂammation of the cartilage of both ears and his
nose, a diagnosis of relapsing polychondritis was considered.
One week later, prednisone therapy was begun at a dose
of 40mg per day. Prompt resolution of his signs and
symptoms occurred. One month later, as prednisone therapy
was being tapered, the patient developed hoarseness and
a severe sore throat. Rigid telescopy in the ENT clinic
found marked swelling of the arytenoids and false vocal
cords. Corticosteroids were increased with resolution of his
symptoms. Still later, iritis of the left eye occurred. The
patient’s eye symptoms responded promptly to an increase
in corticosteroid therapy. Interestingly, after six weeks of
prednisone 30mg per day, the patient’s beard regrew and he
shaved for the ﬁrst time in 28 years! (Figure 2) There was no
regrowth of hair on other parts of his body, including the
scalp, axillae, eyelashes, or perineal area. Eleven months into
the patient’s illness, he developed profound sensorineural
hearing loss in both ears. An autoimmune basis for his
complaints was suspected. There was no history of fever,
weight loss, prior similar symptoms, wheezing, or shortness
of breath. The physical examination was unremarkable.
Routine laboratory studies that were normal or within
the expected range included complete blood count, compre-
hensive metabolic proﬁle, urinalysis, prostate-speciﬁc anti-
gen, thyroid stimulating hormone, c and p antineutrophilic
cytoplasmic antibodies, and protein-electrophoresis with
immunoglobulins. Sedimentation rate was 43mm/hr and
theantimicrosomalantibodytestwaspositiveat1 : 400dilu-
tion. Pulmonary function tests showed a forced expiratory
volume of 78% of predicted and the vital capacity was 71%2 Case Reports in Medicine
Table 1: Summary of cases.







1( f e m a l e ) 5 6 Y e s 14 years no no Kronborg I. J. 1981
2( f e m a l e ) 1 3 N o unknown yes tonsillitis Rozin A. P. 2003
3( m a l e ) 7 1 Y e s 28 Beard only Poison ivy Starr J. C. 2010
Figure 1: Ear inﬂammation with sparing of ear lobe.
Figure 2: Chin whiskers after prednisone therapy.
of predicted, and the carbon monoxide diﬀusion test was
normal. An antibody type II collagen was strongly positive
at 65eu/mL (positive greater than 25eu/mL). These ﬁndings
were felt consistent with relapsing polychondritis. A chest
roentgenogram was normal.
3. Discussion
Alopecia areata is considered a systemic disease, as tissues
otherthanhairfolliclesareinvolved[7].Nailchangesinclude
pits, ridges, and reddening of the lunulae. Eye changes
have included defects in the retinal pigmentary epithelium
[8]. Our patient and the two previously cited cases might
suggest that relapsing polychondritis could be yet another
systemic manifestation of alopecia areata. In each case,
long-term alopecia areata preceded the onset of relapsing
polychondritis. Two of the three patients had a particularly
severe form of alopecia areata, that is, alopecia universalis.
The third patient had recalcitrant alopecia areata (Table 1).
In alopecia areata, the immune response is directed at
the hair follicles and helper lymphocytes are thought to
play an important role in pathogenesis [3]. Malgouries et al.
have surmised that the helper t-cell inﬁltration of the hair
bulb correlates with loss of chondroitin sulfate, an important
proteoglycan in both hair follicles and cartilage [9]. In point
offact,animportantearlyﬁndinginrelapsingpolychondritis
is loss of proteoglycans in cartilage [10]. Additionally,
a cell-mediated immune response to proteoglycans has
been reported in relapsing polychondritis [11]. One could
envision a scenario in which lymphocytes, initially active
against chondroitin sulfate in the hair follicle, later attack
chondroitin sulfate in ear cartilage and perhaps other tissues.
It should be noted that chondroitin sulfate helps maintain
immune privilege in the hair follicle.
Two weeks prior to the onset of relapsing polychondritis
our patient developed poison ivy on his right forearm. The
area improved with conservative therapy. As in relapsing
polychondritis, both helperandsuppressort-cellsareimpor-
tant in the pathogenesis of allergic contact dermatitis [12].
We could not, however, identify literature support for hapten
formation between urushiol and proteoglycans. Thus, the
relationship between the illness we describe and allergic
contact dermatitis remains unknown.
Our patient had a regrowth of beard hair following
corticosteroid therapy. The ﬁrst patient reported with relaps-
ing polychondritis following alopecia areata, a 57-year-old
woman, had no regrowth of scalp or body hair follow-
ing prednisolone therapy. The second previously reported
patient (a 13-year-old girl) had conventional alopecia areata,
followed by relapsing polychondritis. She had a variable
response to prednisone therapy but a more lasting response
to a combination of cotrimoxazole treatment and pred-
nisone. Her alopecia areata disappeared with this therapy.
Interestingly, in a mouse model, androgens oﬀer resistance
to alopecia areata and estrogens promote susceptibilityCase Reports in Medicine 3
to alopecia areata [13]. Conceivably, our patient’s beard
regrowth may have been inﬂuenced by an androgen milieu
in the beard area.
In summary, we present a third case of relapsing poly-
chondritis following long standing alopecia areata. This rare
association seems immunologically plausible. As noted by
Tobin, both cell-mediated immunity and humoral immunity
are likely important in alopecia areata [7]. Likewise, it is
possible that there are multiple “targets” of any immune
response [7]. As suggested by Tosti et al., damage to retinal
pigmentary epithelium might follow an immune attack on
hair follicle melanocytes [8]. In a similar vein, relapsing
polychondritis could follow a long-term immune assault on
a hair follicle proteoglycan, chondroitin sulfate, which is also
abundantinearcartilageandothercartilage-bearingtissues.
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